Pediatrix director granted 7,196 restricted shares

Rucker Michael A. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Rucker Michael A. reported acquisition or exercise transactions in this Form 4 filing.

Pediatrix Medical Group director Michael A. Rucker received a grant of 7,196 shares of common stock as an equity award. The restricted shares were granted at no cash cost under the company’s Amended and Restated 2008 Incentive Compensation Plan and will vest on May 7, 2027. Following this award, Rucker directly holds 66,297 shares of Pediatrix Medical Group common stock.

Insider Trade Summary

Grant/Award: 7,196 shares

Grant/Award 1 txn

Insider Rucker Michael A.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,196	$0.00	$0.00

Holdings After Transaction: Common Stock — 66,297 shares (Direct)

Footnotes (1)

1. F1. Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.

Key Figures

Restricted stock grant: 7,196 shares Grant price: $0.0000 per share Shares after transaction: 66,297 shares +1 more

4 metrics

Restricted stock grant 7,196 shares Annual equity award granted May 7, 2026

Grant price $0.0000 per share Non-cash restricted stock award

Shares after transaction 66,297 shares Director’s direct holdings following grant

Vesting date May 7, 2027 Restricted shares vesting schedule

Key Terms

Restricted shares, Amended and Restated 2008 Incentive Compensation Plan, annual equity award, vest

4 terms

Restricted shares financial

"Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Amended and Restated 2008 Incentive Compensation Plan financial

"Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan"

annual equity award financial

"Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award."

vest financial

"Shares will vest on May 7, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pediatrix Medical Group (MD) report for Michael A. Rucker?

Pediatrix Medical Group reported that director Michael A. Rucker received a grant of 7,196 restricted common shares as an annual equity award, increasing his direct holdings to 66,297 shares after the transaction.

Was the Pediatrix Medical Group (MD) share grant to Michael A. Rucker a market purchase?

No, the 7,196 Pediatrix Medical Group shares were granted to Michael A. Rucker as a restricted stock award at no cash cost, rather than purchased in the open market, as part of the company’s equity compensation program.

When do Michael A. Rucker’s restricted Pediatrix Medical Group (MD) shares vest?

Michael A. Rucker’s 7,196 restricted Pediatrix Medical Group shares will vest on May 7, 2027. Until vesting, the award remains subject to the terms and conditions of the company’s Amended and Restated 2008 Incentive Compensation Plan.

How many Pediatrix Medical Group (MD) shares does Michael A. Rucker hold after this Form 4?

After receiving the 7,196-share restricted stock grant, Michael A. Rucker directly holds 66,297 shares of Pediatrix Medical Group common stock, according to the Form 4 insider transaction report filed with regulators.

What plan governed Michael A. Rucker’s equity grant from Pediatrix Medical Group (MD)?

The restricted share grant to Michael A. Rucker was made under Pediatrix Medical Group’s Amended and Restated 2008 Incentive Compensation Plan, which provides for equity-based awards such as annual stock grants to eligible participants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 05:43 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rucker Michael A.

(Last) (First) (Middle)

1301 CONCORD TERRACE

(Street)

SUNRISE FLORIDA 33323

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		A(1)		7,196	A	$0	66,297	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.

	Mary Ann E. Moore, Attorney-in-Fact	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)